A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2001
10/24/2001	CN1319140A Recombinant CELO virus and CELO virus DNA
10/24/2001	CN1319137A Keratinocyte derived interferon
10/24/2001	CN1319134A Genes of 1-desoxy-D-xylulose biosynthetic pathway
10/24/2001	CN1319133A Short peptides which selectively modulate activity of protein kinases
10/24/2001	CN1319131A Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC
10/24/2001	CN1319021A Chemokine receptor antagonist and ocyclosporin in combined therapy
10/24/2001	CN1319012A Method for treating diabetes employing ap2 inhibitor and combination
10/24/2001	CN1319008A Hydroxamate-containing cysteine and serine protease inhibitors
10/24/2001	CN1319003A Protein formulations
10/24/2001	CN1318647A New NADH dehydrogenase and its encoding polynucleotide sequence
10/24/2001	CN1318644A Construction process of recombined human single-chain interleukin-12
10/24/2001	CN1318563A Human testicular development specific protein-6 gene encoded protein
10/24/2001	CN1318562A Human testicular development specific protein-14 gene encoded protein
10/24/2001	CN1318561A Human testicular mitosis dynein gene encoded protein
10/24/2001	CN1318560A Human testicular specific protein-1 gene encoded protein
10/24/2001	CN1318559A Human sperm skelemin gene encoded protein
10/24/2001	CN1318558A Human testicular development specific protein-12 gene encoded protein
10/24/2001	CN1318557A Human testicular specific protein-10 gene encoded protein
10/24/2001	CN1318556A Human nuclear transcription factor-2 gene encoded protein
10/24/2001	CN1318552A New actin and polynucleotide sequence for encoding it
10/24/2001	CN1318416A Method of preparing oil-phase oral insulin preparation
10/24/2001	CN1318415A Buccal tablet of epidermal growth factor
10/24/2001	CN1318414A Preparation of neuroregulator
10/24/2001	CN1073626C Productive technology for A-type botulism crystalline toxin and frozen-dried protective liquid needed for producing said toxin
10/23/2001	US6307129 Herbicide tolerant plants, plant tissue or plant cells having altered protoporphyrinogen oxidase activity
10/23/2001	US6307090 Acylated oligopeptide derivatives having cell signal inhibiting activity
10/23/2001	US6307038 Nucleotide sequences coding fusion protein for use in treatment of oxidative stress
10/23/2001	US6307035 Nucleotide sequences coding protein associated with cancer; for use in the diagnosis and treatment of cancer
10/23/2001	US6307032 With von willebrand factor, comprising contacting composition with an immunoaffinity chromatography material, eluting complex with first elution buffer, eluting non-complexed factor viii or von willebrand factor with second buffer
10/23/2001	US6307031 Beta taipoxin as a cell growth factor and method
10/23/2001	US6307030 Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions
10/23/2001	US6307027 Bradykinin B1 receptor antibodies
10/23/2001	US6307025 VCAM fusion proteins and DNA coding therefor
10/23/2001	US6307024 Polypeptides; for use in the proliferation of hematopoietic cells
10/23/2001	US6307023 Gene encoding a polypeptide having pre-B cell growth-supporting ability
10/23/2001	US6307022 Def
10/23/2001	US6307021 Polypeptide; for use in the treatment of defects associated with amplified or decreased apoptosis
10/23/2001	US6307019 Axin gene and uses thereof
10/23/2001	US6307017 Linear analog of biologically active mammalian gastrin-releasing peptide, amphibian bombesin, or mammalian growth hormone releasing factor; treatment of gastrointestinal disorders, diabetes, cancer
10/23/2001	US6307016 Broad-spectrum antimicrobial peptides effective against a wide variety of microbes, including bacteria; antibiotic peptides
10/23/2001	US6307015 Mammalian checkpoint genes and proteins
10/23/2001	US6306993 Method and composition for enhancing transport across biological membranes
10/23/2001	US6306922 Macromer polymers crosslinked by photopolymerization
10/23/2001	US6306911 Enzyme inhibitors
10/23/2001	US6306909 Anti-epileptogenic agents
10/23/2001	US6306900 Enteric coated pharmaceutical compositions
10/23/2001	US6306892 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
10/23/2001	US6306875 Growth-hormone secretagogues
10/23/2001	US6306832 Peptide antiestrogen compositions and methods for treating breast cancer
10/23/2001	US6306831 Transplacental delivery of oligonucleotides
10/23/2001	US6306829 Administering complementary oligonucleotide to prevent gene expression; treating disorders of angiogenesis and neovascularization and psoriasis
10/23/2001	US6306827 Method for preventing and/or treating renal disease
10/23/2001	US6306826 Administering angiotensin ii receptor inhibitor daily after myocardial infarction; reducing dosage
10/23/2001	US6306825 Cyclosporin galenic forms
10/23/2001	US6306824 Uses of lipopolysaccharide binding protein
10/23/2001	US6306823 Distillation, chromatography
10/23/2001	US6306822 Phosphopeptides and methods of treating bone diseases
10/23/2001	US6306820 Combination therapy using a TNF binding protein for treating TNF-mediated diseases
10/23/2001	US6306819 Method for regulating size of vascularized normal tissue
10/23/2001	US6306663 Controlling protein levels in eucaryotic organisms
10/23/2001	US6306655 Antisense inhibition of C/EBP alpha expression
10/23/2001	US6306654 Nucleotide sequence coding mutant gonadotrophin hormone; for treatment of reproduction defects
10/23/2001	US6306653 Peptide for use in diagnosis, prevention and treatment of mammary gland cancer
10/23/2001	US6306651 Bone marrow hematopoietic stem cell; for use in prevention of graft versus host disease
10/23/2001	US6306648 Amino acid sequences for use as enzyme inhibitors; for use in preventing and treatment of oncogenesis; antitumor agents
10/23/2001	US6306626 Immunoglobulin; for use in preferential killing of hybridoma or lymphocytes
10/23/2001	US6306624 Retinoid metabolizing protein
10/23/2001	US6306623 Leptospiral major outer membrane protein LipL32
10/23/2001	US6306622 cDNA encoding a BMP type II receptor
10/23/2001	US6306618 Contacting sample with enzyme capable of degrading homocysteine, and determining any reaction product(s) formed
10/23/2001	US6306612 Methods of facilitating vascular growth
10/23/2001	US6306606 Antisense modulation of MP-1 expression
10/23/2001	US6306604 EPO primary response gene, EPRG3Spt
10/23/2001	US6306586 Methods and compositions for the diagnosis and treatment of cataracts
10/23/2001	US6306580 Preparation of human papillomavirus E1 having helicase activity and method therefor
10/23/2001	US6306579 Immunoassay by incubating sample with at least one peptide from ns3 region having at least one covalently modified cysteine or replaced cysteine, then determining binding of antibody to peptide
10/23/2001	US6306575 Negative selection process for recovering stem cells from mixed cell sample by rection with anibodies against glycophorin a, cd3, cd24, cd16, c14, and a tumor specific antigen; removing labeled cells; and recovering preparation
10/23/2001	US6306440 Forming solution of insulin in solvent and a substance that enhances absorption of insulin in lower respiratory tract; removing solvent to obtain solid; forming into powder; incorporating powder into dry powder inhaler device
10/23/2001	US6306434 Pharmaceutical composition comprising cyclosporin solid-state microemulsion
10/23/2001	US6306432 High and low load formulations of IGF-I in multivesicular liposomes
10/23/2001	US6306423 Biocompatible implant for continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years
10/23/2001	US6306420 Obtaining implantable device for automatic delivery of an active ingredient according to adjustable delivery profile; providing energy to controller and actuator to move drug from reservoir to transit area to deliver to body fluids
10/23/2001	US6306406 Drug delivery system involving interaction between protein or polypeptide and hydrophobic biodegradable polymer
10/23/2001	US6306403 Intracranial administration of botulinum toxin into a globus palladius or into ventrolateral thalamus, thereby reducing a dyskinesia of parkinson's disease
10/23/2001	US6306402 Compounds and methods for the diagnosis and treatment of EHRLICHIA infection
10/23/2001	US6306397 Variants of human papilloma virus antigens
10/23/2001	US6306396 Compounds and methods for the diagnosis and treatment of B. microti infection
10/23/2001	US6306395 Fas antigen derivatives
10/23/2001	US6306394 Nucleic acids, proteins, and methods of use of granulocytic ehrlichia
10/23/2001	US6306393 Administering to subject having a b-cell related malignancy a therapeutic composition comprising a pharmaceutically acceptable carrier and a combination of at least one naked anti-cd19 antibody and an anfi-cd20 antibody
10/23/2001	US6306392 Prevention and/or treatment of alterations of those organs which perform metabolic function, such as liver, kidneys, cardiovascular system and brain; for therapy of hepatosis, nephropathies and cardiovascular or cerebral damage damage
10/23/2001	US6306389 For identification of a molecule or a marker for transformed cells, such as cancer; for diagnosis and therapy
10/23/2001	US6306306 Chromatographic process for obtaining highly purified cyclosporin A and related cyclosporins
10/23/2001	US6305380 Administering histamine agonist or ht3 receptor antagonist to activate natural killer cells and treat viral diseases
10/23/2001	CA2302963C Soft gelatin capsule manufacture
10/23/2001	CA2261026C Genetically engineered immunoglobulins with specificity for glycated albumin
10/23/2001	CA2215345C Bacteriocins produced by ruminal bacteria
10/23/2001	CA2183862C Stabilized composition for oral administration of peptides
10/23/2001	CA2125043C Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin
10/23/2001	CA2048407C Gonadoliberin antagonists

1 ... 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 ... 3163